CN116173104A - 一种治疗普感和流感的外用中药组合物 - Google Patents
一种治疗普感和流感的外用中药组合物 Download PDFInfo
- Publication number
- CN116173104A CN116173104A CN202111436394.1A CN202111436394A CN116173104A CN 116173104 A CN116173104 A CN 116173104A CN 202111436394 A CN202111436394 A CN 202111436394A CN 116173104 A CN116173104 A CN 116173104A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- cold
- treating
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010022000 influenza Diseases 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 201000009240 nasopharyngitis Diseases 0.000 title claims abstract description 22
- 230000000699 topical effect Effects 0.000 title claims description 8
- 239000003814 drug Substances 0.000 claims abstract description 65
- 230000000694 effects Effects 0.000 claims abstract description 26
- 239000003921 oil Substances 0.000 claims abstract description 20
- 235000019198 oils Nutrition 0.000 claims abstract description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 16
- 239000008158 vegetable oil Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 12
- 210000004072 lung Anatomy 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- 231100000331 toxic Toxicity 0.000 claims abstract description 5
- 230000002588 toxic effect Effects 0.000 claims abstract description 5
- 229920000742 Cotton Polymers 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 238000007598 dipping method Methods 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 21
- 238000007789 sealing Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 6
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 238000005282 brightening Methods 0.000 claims description 2
- 210000003928 nasal cavity Anatomy 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 5
- 241000205585 Aquilegia canadensis Species 0.000 abstract description 5
- 229940116229 borneol Drugs 0.000 abstract description 5
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 5
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000011248 coating agent Substances 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 210000002850 nasal mucosa Anatomy 0.000 abstract description 2
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- 240000004534 Scutellaria baicalensis Species 0.000 description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 229960003965 antiepileptics Drugs 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000009982 effect on human Effects 0.000 description 2
- 239000002389 essential drug Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗普感和流感的外用中药组合物,其中药组份及其重量配比为:植物油500、金银花10~30、连翘9~20;黄芩15~30;冰片0.05~2.0;并公开了其制备方法和用来治疗感冒的使用方法,用灭菌棉签浸沾本发明制得感冒外用中药油,均匀地涂抹在鼻孔里内壁,涂抺结束后,深吸入肺三次以上,每隔4小时涂抹一次,一日三次以上,一个疗程4天,一般患者一个疗程可治愈,在治疗期间需注意保暖,以防受凉。采用鼻腔涂抺治疗法,是靠鼻腔粘膜吸收,从而最大化避免全身用药的副作用,使得药物在鼻腔局部生物利用最大化。减少肝脏和肾脏的毒副作用,安全用药系数明显提高。
Description
技术领域:
本发明涉及一种治疗感冒的中药,尤其涉及一种用于治疗普通感冒和流行性感冒的外用中药。
背景技术:
普通感冒和流行性感冒的治愈是一个复杂的过程,世界各国的学者都在探索治疗普通感冒和流行性感冒治愈的机理,为缩短治疗时间及减少并发症而努力。现在治疗普通感冒和流行性感冒的方法有如下几种:
第一种,西药治疗法,通过注射、输液方式将抗病毒消炎西药注入人体内进行抗菌杀毒,并补充能量,提高人体抵抗力;或者采用口服抗病毒消炎类西药;
第二种,中药内服治疗法,通过服用感冒胶襄、感冒灵等中药冲剂等中成药进行中医治疗。
第三种,物理退热法,用冷湿毛巾、酒精擦棉等降温物对人体进行局降温,达到退热之目的,通过人体自身免疫来调节抗源,达到自我康复的目的;
从现有治疗感冒的方案可知,采用西医治疗都必须使用化学药剂,对人体的副作用大。
通过中药内服方法治疗,病人必须定期定量服用颗粒剂或汤剂,现在越来越多的患者都希望使用中药治疗方案,以减少对人体的伤害。
但是,中药味苦,难入口,尤其对儿童更难接受,广大家长都希望有一种外用的冒感治疗药。
我国的中医历史悠久,有各种治疗感冒的中医治疗方法,中医认为感冒是风寒、暑湿、燥火致病,只要解表达邪,扶正培本方能治愈。
申请人根据祖传感冒中医治疗秘方进行了长期的理疗试验和改良,获得了一种治疗普通感冒和流行性感冒的外用中药组合物。
发明内容:
本发明的目的是提供一种治疗普感和流感的外用中药组合物,它具有开窍醒神、宣肺清热、辛凉解表、抗炎解毒的功效,通过外用涂抺的方法就能治疗普通感冒和流行性感冒,不仅见效快,而且对人体无任何副作用,患者易接受。
本发明的解决方案是基于中国医学对感冒的治疗机理,参考现代中药药理研究成果,从中医医药宝库中筛选出清热解毒、燥湿、宣肺、清热、解表扶正的天然药物,按中医理论配方获得最佳清热解毒、抗炎扶正疗效,从而达到治愈普感和流感之目的。
本发明采取的技术方案如下:
1、一种治疗普感和流感的外用中药组合物,其特征是:包括如下药组份及其重量配比为:
其中,金银花、连翘、黄芩、冰片均为药店市购的干货。
植物油具有润燥杀虫、散火丹、消肿毒的作用。
金银花具有清热利湿、解毒、消肿,主要用于感冒引起的咳嗽、声音嘶哑、咳黄痰、流黄鼻鼻涕等。
连翘的功效与作用,主要是清热去火、消肿消结、抑菌消炎抗病毒,能抑止感冒病毒的特异性。也可以降低其它病毒感染对人类人体的损害,对病毒和细菌感染有很好的抑制和减轻功效。
黄芩的功效作用,清热燥湿、凉血解毒,肺热咳嗽,咳黄痰、咳血,具有清热解毒的作用,是清肺热的要药。
冰片的功效与作用,具有清热、止痛、开窍醒神功效作用,还具有抗炎、抗菌、抗惊厥、抗病毒的作用。
进一步,治疗普感和流感的外用中药组合物中各中药组份的优选重量配比为:
更进一步,治疗普感和流感的外用中药组合物中各中药组份的最佳重量配比为:
更进一步,所述植物油为现榨的菜籽油。
本发明所述治疗普感和流感的外用中药组合物的制备方法包括以下步骤:
步骤一,中药粉末体混合物的制备:
按各中药组份重量配比称取金银花、连翘、黄芩、冰片原料并研磨为细末,过100目筛,将所有中药末体混合均匀,制得中药末体混合物,密封备用;
步骤二,原膏的制备:
取现榨天然植物油1.5千克,倒进容器中加热至30~40度,然后将步骤一中的药末体称取1.5~2.0千克加入容器中,熬成约2.5千克~2.8千克的原膏,封存备用;
步骤三,油稀释:
将步骤二获得的原膏用同质的植物油进行油稀释,按2.5:30的重量比进行油稀释,即将2.5千克的原膏倒进盛有30千克同质植物油的容器中进行勾兑,勾兑时搅拌均匀,搅拌完封闭,在室温条件下储存120~150小时后开封再次搅拌,搅拌到颜色发黑发亮,然后再封存,在室温条件下发酵240小时以上;
步骤四,将步骤三获得的中药油液混合物进行滤渣,去除药渣,分装封存,然后放入温度为5~10度的水池或土坑中掩埋120~360小时,以去火毒,即得目标物——感冒外用中药油。
使用感冒外用中药油治疗感冒的使用方法:
用灭菌棉签浸沾本发明制得感冒外用中药油,均匀地涂抹在鼻孔里内壁,涂抺结束后,深吸入肺三次以上,每隔4小时涂抹一次,一日三次以上,一个疗程4天,一般患者一个疗程可治愈,在治疗期间需注意保暖,以防受凉。严重的感冒患者可能需用使用2~3个疗程,但对人体无副作用,若3个疗程无效则停用,更换其它医疗方案。
由于鼻腔是人们呼吸的主要通道,也是呼吸性疾病传染的关键部位和器官,采用鼻腔涂抺治疗法,通过靠鼻腔粘膜吸收,有效的药份能直接进入人体呼吸的全流程,从而最大化地发挥药效,克服了内服药的二次转换降效缺陷,同时避免药物对胃、肠等消化道的激和影响,且对人体无任何毒副作用,使得药物通过鼻腔流入全程呼吸道,并在全程发挥吸收和杀灭病毒,实现直接、精准、高效杀灭和抑制,达到快速治愈的效果。能最大化减少药物肝脏和肾脏的毒副作用,安全用药系数明显提高。
具体实施方式:
下面举例说明本发明的具体实施方式:
一种治疗普感和流感的外用中药组合物,其中药组份及其重量配比为:
其中,金银花、连翘、黄芩、冰片均为药店市购的干货。
现榨菜籽油具有润燥杀虫、散火丹、消肿毒的作用。
金银花具有清热利湿、解毒、消肿,主要用于感冒引起的咳嗽、声音嘶哑、咳黄痰、流黄鼻鼻涕等。
连翘的功效与作用,主要是清热去火、消肿消结、抑菌消炎抗病毒,能抑止感冒病毒的特异性,也可以降低其它病毒感染对人类人体的损害,对病毒和细菌感染有很好的抑制和减轻功效。
黄芩的功效作用,清热燥湿、凉血解毒,肺热咳嗽,咳黄痰、咳血,具有清热解毒的作用,是清肺热的要药。
冰片的功效与作用,具有清热、止痛、开窍醒神功效作用,还具有抗炎、抗菌、抗惊厥、抗病毒的作用。
本发明所述治疗普感和流感的外用中药组合物的制备方法包括以下步骤:
步骤一,中药粉末体混合物的制备:
按各中药组份重量配比称取金银花、连翘、黄芩、冰片原料并研磨为细末,过100目筛,将所有中药末体混合均匀,制得中药末体混合物,密封备用;
步骤二,原膏的制备:
取现榨天然菜籽油1.5千克,倒进容器中加热至30~40度,然后将步骤一中的药末体称取1.6千克加入容器中,熬成约2.5千克的原膏,封存备用;
步骤三,油稀释:
将步骤二获得的原膏用同质的植物油进行油稀释,按2.5:30的重量比进行油稀释,即将2.5公斤的原膏倒进盛有30千克同质植物油的容器中进行勾兑,勾兑时搅拌均匀,搅拌完封闭储存120~150小时后开封再次搅拌,搅拌到颜色发黑发亮,然后再封存发酵240小时以上;
步骤四,将步骤三获得的中药油液混合物进行滤渣,去除药渣,分装封存,然后放入温度为5~10度的水池或土坑中掩埋120~360小时,以去火毒,即得目标物——感冒外用中药油。
申请人用本发明制得的感冒外用中药油对流行性感冒和普通感冒分别进行了治疗临床试验,参与临床治疗试验病人数分别为12人和17人。
通过临床治疗试验可得到如下结论:
1、用本发明的感冒外用中药油对流行性感冒进行治疗,在12位临床病例中有10人在1个疗程中治愈,其中,有7人在使用2天后就治愈,3-4天的病患是怕病情返弹,增加1天攻固性治疗。有2人在1个疗程中病情减轻但未治愈,因此,总有效率为100%,4天治愈率为83.3%。
2、用本发明的感冒外用中药油对流行性感冒进行治疗,在17位临床病例中有11人在1个疗程中治愈,其中,有7人在使用2天后就治愈了,3-4天的病患是怕病情返弹,坚持进行了攻固性治疗,达到一个疗程。
有3人在2个疗程中治愈,有1人在3个疗程中治愈。
用本发明感冒外用中药油对普通感冒进行治疗的有效率为100%,1个疗程治愈率为64.7%。2个疗程治愈率为82.3%;3个疗程治愈率为100%。
综上所述,采用本发明所述的中药组合物来对流行性感冒和普通感冒进行治疗,无需内服,只要按要求在鼻腔内涂擦,就可以清热解毒、开窍醒神、宣肺解表,一般使用2天后症状消失。
本发明不仅限于上述具体的实施病例,中药组份还可增添其它辅助原料,植物油的具体种类也可更换,只要原料药的质量配比满足配比范围,均可达到本发明的效果。
Claims (6)
4.根据权利要求1治疗普感和流感的外用中药组合物,其特征是:所述植物油为现榨的菜籽油。
5.所述治疗普感和流感的外用中药组合物的制备方法,包括以下步骤:
步骤一,中药粉末体混合物的制备:
按各中药组份重量配比称取金银花、连翘、黄芩、冰片原料并研磨为细末,过100目筛,将所有中药末体混合均匀,制得中药末体混合物,密封备用;
步骤二,原膏的制备:
取现榨天然植物油1.5千克,倒进容器中加热至30~40度,然后将步骤一中的药末体称取1.5~2.0千克加入容器中,熬成约2.5千克~2.8千克的原膏,封存备用;
步骤三,油稀释:
将步骤二获得的原膏用同质的植物油进行油稀释,按2.5:30的重量比进行油稀释,即将2.5千克的原膏倒进盛有30千克同质植物油的容器中进行勾兑,勾兑时搅拌均匀,搅拌完封闭,在室温条件下储存120~150小时后开封再次搅拌,搅拌到颜色发黑发亮,然后再封存,在室温条件下发酵240小时以上;
步骤四,将步骤三获得的中药油液混合物进行滤渣,去除药渣,分装封存,然后放入温度为5~10度的水池或土坑中掩埋120~360小时,以去火毒,即得目标物——感冒外用中药油。
6.使用感冒外用中药油治疗感冒的使用方法:
用灭菌棉签浸沾本发明制得感冒外用中药油,均匀地涂抹在鼻孔里内壁,涂抺结束后,深吸入肺三次以上,每隔4小时涂抹一次,一日三次以上,一个疗程4天,一般患者一个疗程可治愈,在治疗期间需注意保暖,以防受凉。
严重的感冒患者可能需用使用2~3个疗程,但对人体无毒副作用,若3个疗程无效则停用,更换其它医疗方案。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111436394.1A CN116173104A (zh) | 2021-11-29 | 2021-11-29 | 一种治疗普感和流感的外用中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111436394.1A CN116173104A (zh) | 2021-11-29 | 2021-11-29 | 一种治疗普感和流感的外用中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116173104A true CN116173104A (zh) | 2023-05-30 |
Family
ID=86431273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111436394.1A Withdrawn CN116173104A (zh) | 2021-11-29 | 2021-11-29 | 一种治疗普感和流感的外用中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116173104A (zh) |
-
2021
- 2021-11-29 CN CN202111436394.1A patent/CN116173104A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327478B (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN104352587B (zh) | 一种治疗鼻炎的软膏 | |
CN103768541A (zh) | 一种治疗慢性支气管炎的药物 | |
CN102772591B (zh) | 一种治疗鼻炎的中空、通气、双层中药栓剂及其制作方法 | |
CN101274024B (zh) | 一种治疗牙疼的药物组合物 | |
CN107095905A (zh) | 一种保健灸条及灸膏 | |
CN110652544A (zh) | 一种治疗鼻炎的药物组合物及其制备方法 | |
CN104189725A (zh) | 一种治疗小儿哮喘的中药组合物 | |
CN101385821B (zh) | 控哮涂膜剂及其制备工艺 | |
CN107823600A (zh) | 治疗小儿寒性咳嗽的中药制剂 | |
CN104547251B (zh) | 一种治疗急性肠炎的脐贴及制备方法 | |
CN116173104A (zh) | 一种治疗普感和流感的外用中药组合物 | |
CN101297954B (zh) | 治疗咳嗽的敷脐药物及制备方法 | |
CN107115454A (zh) | 一种可有效治疗肺炎的中药组合物及其制备方法 | |
CN101062186A (zh) | 一种消炎止痛的外敷药-火龙液 | |
CN101703590B (zh) | 一种治疗冠心病的中药 | |
CN105194637A (zh) | 一种用于治疗感冒的中药制剂及制备方法 | |
CN107296906A (zh) | 中药组合物及其在肺炎治疗中的应用 | |
CN104815293A (zh) | 一种治疗中耳炎的中药片剂及其制备方法 | |
CN109464646A (zh) | 止咳儿科外用按摩软膏配方、制备方法及应用 | |
CN104491391A (zh) | 一种治疗咽炎的中药组合物 | |
CN118236355A (zh) | 一种化痰解毒的水凝胶喉贴及其制备方法和应用 | |
CN112546194A (zh) | 宽胸理气口服液 | |
CN111358928A (zh) | 一种治疗过敏性鼻炎的中药组合物及使用方法 | |
CN102988481A (zh) | 治疗风湿、类风湿的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230530 |